Abbott’s (ABT) diversified business portfolio is well-positioned to drive continued momentum in 2024. However, a challenging macroeconomic environment continues to dent Abbott’s business globally. The stock carries a Zacks Rank #3 (Hold) currently.Abbott continues to expand its Diagnostics business foothold (consisting of 22.2% of the total revenues in the first quarter of 2024). Over the past few quarters, the company has witnessed increased demand for routine diagnostics, particularly in the United States ...